PT3142749T - Composição para viscossuplementação compreendendo ulvano para tratamento de artrite - Google Patents

Composição para viscossuplementação compreendendo ulvano para tratamento de artrite

Info

Publication number
PT3142749T
PT3142749T PT157267485T PT15726748T PT3142749T PT 3142749 T PT3142749 T PT 3142749T PT 157267485 T PT157267485 T PT 157267485T PT 15726748 T PT15726748 T PT 15726748T PT 3142749 T PT3142749 T PT 3142749T
Authority
PT
Portugal
Prior art keywords
ulvan
treating arthritis
viscosupplement
composition
viscosupplement composition
Prior art date
Application number
PT157267485T
Other languages
English (en)
Original Assignee
Stemmatters Biotecnologia E Medicina Regenerativa Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemmatters Biotecnologia E Medicina Regenerativa Sa filed Critical Stemmatters Biotecnologia E Medicina Regenerativa Sa
Publication of PT3142749T publication Critical patent/PT3142749T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT157267485T 2014-05-16 2015-05-18 Composição para viscossuplementação compreendendo ulvano para tratamento de artrite PT3142749T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1408752.2A GB201408752D0 (en) 2014-05-16 2014-05-16 Arthritis treatment

Publications (1)

Publication Number Publication Date
PT3142749T true PT3142749T (pt) 2020-03-02

Family

ID=51134999

Family Applications (1)

Application Number Title Priority Date Filing Date
PT157267485T PT3142749T (pt) 2014-05-16 2015-05-18 Composição para viscossuplementação compreendendo ulvano para tratamento de artrite

Country Status (7)

Country Link
US (1) US20170216343A1 (pt)
EP (1) EP3142749B1 (pt)
JP (1) JP2017519731A (pt)
CN (1) CN106573013B (pt)
GB (1) GB201408752D0 (pt)
PT (1) PT3142749T (pt)
WO (1) WO2015174872A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3105924B1 (fr) 2020-01-08 2024-01-19 Odycea Principe actif cosmetique issu d’algues de la classe des ulvophycees renforçant l’effet barriere, la plasticite, la desquamation et l’homeostasie de l’epiderme, composition l’incluant et utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050196410A1 (en) * 2004-03-05 2005-09-08 Daniels Bruce A. Seaweed extract composition for treatment of inflammation
FR2868252B1 (fr) * 2004-03-30 2006-07-21 Cie Financiere Et De Participa Utilisation des ulvanes comme eliciteurs des mecanismes d'absorption de l'azote et de la synthese proteique
CN103860582A (zh) * 2004-12-30 2014-06-18 建新公司 用于关节内粘弹性补充的方案
JP2009057285A (ja) * 2005-12-21 2009-03-19 Konan Kako Kk 血管新生阻害剤及びその利用
WO2007072965A1 (ja) * 2005-12-21 2007-06-28 Konan Chemical Manufacturing Co., Ltd. 血管新生阻害剤及びその利用
FR2954165B1 (fr) * 2009-12-18 2012-01-13 Jean-Noel Thorel Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes

Also Published As

Publication number Publication date
WO2015174872A1 (en) 2015-11-19
GB201408752D0 (en) 2014-07-02
CN106573013B (zh) 2020-01-17
EP3142749A1 (en) 2017-03-22
US20170216343A1 (en) 2017-08-03
JP2017519731A (ja) 2017-07-20
EP3142749B1 (en) 2019-11-20
CN106573013A (zh) 2017-04-19

Similar Documents

Publication Publication Date Title
SMT202200370T1 (it) Composizione per il trattamento del cancro
PT3492632T (pt) Métodos para o tratamento de materiais que contêm lítio
SG11201705093UA (en) Composition for treating il-6-related diseases
IL249454A0 (en) Treatment of lymphomas
IL252716A0 (en) Anti-csf1r antibodies for the treatment of pvns
IL254393A0 (en) Methods for treating diseases associated with pathological changes in protein
GB201410905D0 (en) Composition
GB201404178D0 (en) Composition
IL249475A0 (en) Methods for treating itching
SG11201605070UA (en) Novel methods for treating cancer
SG11201702512RA (en) Synergistic composition for osteoarthritis
GB201403017D0 (en) Composition
GB201414910D0 (en) Composition
EP3233121A4 (en) Methods for treating inflammatory arthritis
GB201403561D0 (en) Composition
GB201414555D0 (en) Composition
SG11201610547WA (en) Solid composition
GB201410493D0 (en) Composition
ZA201608407B (en) Stain treatment compositions
EP3130586A4 (en) Process for treating homoserine-based compound
PL3113919T3 (pl) Sposób powlekania fragmentu powierzchni
GB201405657D0 (en) Additive carrying composition
GB201404390D0 (en) Composition
IL249616A0 (en) Methods for treating inflammation
ZA201608405B (en) Stain treatment compositions